Skip to site menu
Skip to page content
CT
Menu
Search
Sections
Home
News
Analysis
Features
Comment & Opinion
Projects
Data Insights
Sectors
Clinical Trials
Approvals
Operations
Outsourced Services
Supply Chain
Data Management
Medical Devices
Themes
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Insights
Deals
Jobs
Filings
Patents
Social Media
Companies
Company A-Z
Company Categories
Product & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Events
Buy Reports
Excellence Awards
Innovation Rankings
Magazine
Newsletters
GlobalData
About Us
Advertise With Us
Contact Us
Our Marketing Solution
GlobalData Reports
Visit GlobalData
From Our Partners
Biopharma Playbooks: Solutions at the Speed of Science
Simplifying clinical data processes
Control and confidence in clinical data management
Optimizing Cell & Gene Therapy Processes
Accelerating Clinical Trials
Community-based research for better reach, retention and results
The next chapter of clinical trial services
Meet critical milestones
The CRO fueled by agility Together exceptional is possible
News
Analysis
Sections
Features
Comment & Opinion
Projects
Data Insights
Latest
The early phase advantage: the key to de-risking your clinical trials
Multiple sclerosis: three trials to watch
‘The time of the Einsteins is over’: Pharma urged to rethink trials for 2050
Sectors
Sections
Clinical Trials
Approvals
Operations
Outsourced Services
Supply Chain
Data Management
Medical Devices
Latest
Kodiak reports follow-up outcomes from APEX study of KSI-101
CERo commences second cohort of AML trial
PALSONIFY (paltusotine) for the Treatment of Acromegaly, USA
Themes
Sections
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Foreign Direct Investment
Latest
ESMO 2025: potential new adjuvant option ensartinib for ALK+ NSCLC
Asbestos-related cancers still prevalent in the UK
Cognivia’s AI software predicts probability of trial patient dropping out
Insights
Sections
Deals
Jobs
Filings
Patents
Social Media
Latest
Q2 2024 update: social responsibility related hiring actvity in the pharma industry
Q2 2024 update: environmental sustainability related hiring actvity in the pharma industry
Q2 2024 update: cloud related hiring actvity in the pharma industry
Companies
Sections
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Latest
Therapeutic Radiopharmaceuticals: Download 2025 Global Report
Could AI help avoid unpredictable and high placebo response rates in pain trials?
ESMO 2025: Data, decisions, and the future of oncology
Webinar & Events
Sections
Webinar & Events
All Webinars & Events
Events
Webinars
On-Demand Webinars
Latest
Simplifying Lyophilized Drug Delivery: Automated Reconstitution with SHL Medical’s Reunite™ Autoinjector
Outsourcing in Clinical Trials China 2026 2026中国临床试验外包大会
Clinical Trial Supply China 2026 中国临床试验供应链大会
Buy Reports
Newsletters
CT
Webinars & Events
Left
Right
All Webinars & Events
Events
Webinars
On-Demand Webinars
AD dementia Alzheimer’s disease Biogen Eisai
Sign up for our daily news round-up!
Give your business an edge with our leading industry insights.
Sign up
View more
